Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALK inhibitors(Anaplastic lymphoma kinase inhibitors), BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | 31 May 2020 |